News
The race to develop effective cancer vaccines has entered a new phase, with late-stage trials from companies like Moderna ...
Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political ...
Mary Talley Bowden, MD, founder of Americans for Health Freedom, an advocacy group that has lobbied against mRNA shots, ...
In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...
Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...
The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...
Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...
When ticks bite us, they release thousands of proteins through their saliva. Could a vaccine for the right ones stop ticks ...
The CDC declared the end of its emergency response to H5N1 avian flu as a health threat to humans, David Murray writes.
TAMPA — Florida’s top health official blasted the manufacturer’s of mRNA COVID-19 vaccines and wants the federal government to do more to help those he described as the “vaccine injured.” Florida ...
A team of researchers in Turkey have discovered multiple signs of stress in the eye after patients took Pfizer's COVID-19 ...
Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results